Ledger.Open graph →
SEC Form D · Amendment · filed September 28, 2015

AXIKIN PHARMACEUTICALS INC

Offering
$11.6M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Peter C. Mcwilliams · San Diego, CAExec · DirectorFred A. Middleton · San Mateo, CADirectorKevin B. Bacon · San Diego, CAExec · DirectorMasaji C. Matsuoka · Menlo Park, CADirectorNeil Shah · GREENWICH, CTExec · DirectorBruce J. Beal · New York, NYExec · DirectorL. J. Cross · New York, NYDirectorMasaji C. Matsuoka · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗